- Home
- Publications
- Publication Search
- Publication Details
Title
Drug repositioning and repurposing for Alzheimer disease
Authors
Keywords
-
Journal
Nature Reviews Neurology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-09-16
DOI
10.1038/s41582-020-0397-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease
- (2019) Michael F. Egan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Current and emerging avenues for Alzheimer's disease drug targets
- (2019) R. Loera‐Valencia et al. JOURNAL OF INTERNAL MEDICINE
- Drug repurposing for Alzheimer’s disease based on transcriptional profiling of human iPSC-derived cortical neurons
- (2019) Gareth Williams et al. Translational Psychiatry
- Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease
- (2019) Robert Howard et al. JAMA Neurology
- Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease
- (2018) Lawrence S. Honig et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pfizer abandons research into Alzheimer’s and Parkinson’s diseases
- (2018) Nigel Hawkes BMJ-British Medical Journal
- Pfizer abandons research into Alzheimer’s and Parkinson’s diseases
- (2018) Nigel Hawkes BMJ-British Medical Journal
- The Renin-Angiotensin System and Antihypertensive Drugs in Alzheimer's Disease: Current Standing of the Angiotensin Hypothesis?
- (2018) Patrick G. Kehoe et al. JOURNAL OF ALZHEIMERS DISEASE
- Losartan-Induced Hypotension Leads to Tau Hyperphosphorylation and Memory Deficit
- (2018) Xinghua Liu et al. JOURNAL OF ALZHEIMERS DISEASE
- Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial
- (2018) Brian Lawlor et al. PLOS MEDICINE
- Emerging treatments for Alzheimer’s disease for non-amyloid and non-tau targets
- (2017) Ayesha Khan et al. Expert Review of Neurotherapeutics
- Angiotensin IV Receptors Mediate the Cognitive and Cerebrovascular Benefits of Losartan in a Mouse Model of Alzheimer's Disease
- (2017) Jessika Royea et al. JOURNAL OF NEUROSCIENCE
- Dementia prevention, intervention, and care
- (2017) Gill Livingston et al. LANCET
- Emerging treatments for Alzheimer’s disease for non-amyloid and non-tau targets
- (2017) Ayesha Khan et al. Expert Review of Neurotherapeutics
- Losartan improves cerebrovascular function in a mouse model of Alzheimer's disease with combined overproduction of amyloid-β and transforming growth factor-β1
- (2016) Panayiota Papadopoulos et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Drug repositioning and repurposing: terminology and definitions in literature
- (2015) Joris Langedijk et al. DRUG DISCOVERY TODAY
- Economic analysis of opportunities to accelerate Alzheimer's disease research and development
- (2014) Troy J. Scott et al. Annals of the New York Academy of Sciences
- Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer’s disease model
- (2014) Brice Ongali et al. NEUROBIOLOGY OF DISEASE
- How Thalidomide Works Against Cancer
- (2014) A. K. Stewart SCIENCE
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- Central angiotensin II-induced Alzheimer-like tau phosphorylation in normal rat brains
- (2012) Minjie Tian et al. FEBS LETTERS
- Drug repositioning for Alzheimer's disease
- (2012) Anne Corbett et al. NATURE REVIEWS DRUG DISCOVERY
- Amantadine: The journey from fighting flu to treating Parkinson disease
- (2012) G. Hubsher et al. NEUROLOGY
- Effects of telmisartan on cognition and regional cerebral blood flow in hypertensive patients with Alzheimer's disease
- (2011) Kazumasa Kume et al. Geriatrics & Gerontology International
- Brain renin-angiotensin—A new look at an old system
- (2011) John W. Wright et al. PROGRESS IN NEUROBIOLOGY
- Determining the minimum clinically important differences for outcomes in the DOMINO trial
- (2010) Robert Howard et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies
- (2010) Craig Anderson et al. LANCET NEUROLOGY
- Protective Effects of Intranasal Losartan in the APP/PS1 Transgenic Mouse Model of Alzheimer Disease
- (2010) Lusine Danielyan et al. REJUVENATION RESEARCH
- Angiotensins in Alzheimer's disease – friend or foe?
- (2009) Patrick G. Kehoe et al. TRENDS IN NEUROSCIENCES
- Telmisartan prevented cognitive decline partly due to PPAR-γ activation
- (2008) Masaki Mogi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started